These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19527484)

  • 1. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma.
    Kirikoshi H; Saito S; Yoneda M; Fujita K; Mawatari H; Uchiyama T; Higurashi T; Goto A; Takahashi H; Abe Y; Inamori M; Kobayashi N; Kubota K; Sakaguchi T; Ueno N; Nakajima A
    Hepatol Res; 2009 Jun; 39(6):553-62. PubMed ID: 19527484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
    Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection.
    Kim JM; Joh JW; Yi NJ; Choi GS; Kwon CHD; Lee KW; Suh KS
    Ann Transl Med; 2020 Mar; 8(6):288. PubMed ID: 32355732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.
    Lazzarotto-da-Silva G; Grezzana-Filho TJM; Scaffaro LA; Farenzena M; Silva RK; de Araujo A; Arruda S; Feier FH; Prediger L; Lazzaretti GS; Alvares-da-Silva MR; Chedid AD; Kruel CRP; Chedid MF
    Langenbecks Arch Surg; 2023 Jan; 408(1):26. PubMed ID: 36639606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
    Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y
    Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.
    Kim W; Cho SK; Shin SW; Hyun D; Lee MW; Rhim H
    Abdom Radiol (NY); 2019 Jun; 44(6):2283-2292. PubMed ID: 30806742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Fu Y; Zhao X; Yun Q; Zhu X; Zhu Y; Li Q; Hu K; Wang J; Qiao Z
    Int J Clin Exp Med; 2015; 8(7):10388-400. PubMed ID: 26379829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.
    Liao M; Huang J; Zhang T; Wu H
    PLoS One; 2013; 8(7):e68453. PubMed ID: 23844203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.
    Becker G; Soezgen T; Olschewski M; Laubenberger J; Blum HE; Allgaier HP
    World J Gastroenterol; 2005 Oct; 11(39):6104-9. PubMed ID: 16273634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma.
    Tamai T; Oshige A; Tabu K; Tabu E; Ijyuin S; Sakae H; Onishi H; Muromachi K; Saisyoji A; Oda K; Kumagai K; Mawatari S; Moriuchi A; Sakurai K; Hori T; Ido A
    Oncol Lett; 2017 Sep; 14(3):3199-3206. PubMed ID: 28927066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C.
    Sun SS; Li WD; Chen JL
    World J Clin Cases; 2022 Nov; 10(33):12156-12163. PubMed ID: 36483812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.